Valeriaan behoort tot de familie van valerianaceae en kent meer dan tweehonderdvijftig genetisch verwante soorten, waarvan met name de Valeriana officinalis op grote schaal als therapeuticum wordt toegepast. De plant komt oorspronkelijk voor in Europa en Azië en is gedomesticeerd in Noord-Amerika. Valeriaan was reeds ten tijde van de oude Griekse en Romeinse culturen in gebruik als relaxans en slaapmiddel. Het fytotherapeuticum werd beschreven door Hippocrates en ook Galenus was in de tweede eeuw na Christus bekend met het gebruik van valeriaan bij slaapproblemen. Tot het midden van de negentiende eeuw was het medicinale gebruik van valeriaan gangbaar in de artsenij. Hoe staat het met de toepasbaarheid in deze tijd?
Beste bezoeker, u heeft geen toegang.
Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.
U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!
Auteur
Figuren
Verschenen in
Referenties
Wichtl M, ed. Valerianae radix. Bisset NG, trans-ed. Herbal Drugs and Phytopharmaceuticals: A Handbook for Practice on a Scientific Basis. Boca Raton, FL: CRC Press: 513-516, 1994.
Blumenthal M, Goldberg A, Brinckmann J. Valerian root. Herbal Medicine: Expanded Commission E Monographs. Newton, MA: Integrative Medicine Communications, 394-400, 2000.
Turner W. Of Valerianae. A New Herbal, Parts II and III. Cambridge University Press, 1995.
van Hellemont J. Fytotherapeutisch compendium, 2e druk. Bohn, Scheltema & Holkema, Utrecht 1988.
Khom S, Baburin I, Timin E, et al. Valerenic acid potentiates and inhibits GABAA receptors. Neuropharmacology 53: 178-187, 2007.
Mills S en Bone K. Principles and Practice of Phytotherapy. Churchill Livingstone, twaalfde druk 2010.
Becker A, Felgentreff F, Schröder H, et al. The anxiolytic effects of a Valerian extract is based on valerenic acid. BMC Complement Altern Med. 2014 Jul 28;14:267.
Neuhaus W, Trauner G, Gruber D, et al. Transport of a GABAA receptor modulator and its derivatives from Valeriana officinalis. Planta Med 74(11): 1338-44, 2008.
Gamma-Aminobutyric acid (GABA) Monograph, Alternative Medicine Review 12(3): 274-279, 2007.
Dietz B, Mahady G, Pauli G, et al. Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Brain Res Mol Brain Res. 138(2): 191-197, 2005.
Kassai F, Schlumberger C, Kedves R, et al. Effect of 5-HT5A antagonists in animal models of schizophrenia, anxiety and depression. Behav Pharmacol. 23(4): 397-406, 2012.
van Calker D, Biber K, Domschke K, et al. The role of adenosine receptors in mood and anxiety disorders. J Neurochem. 151(1): 11-27, 2019.
Vincenzi F, Borea P, Varani K. Anxiolytic properties of A1 adenosine receptor PAMs. Oncotarget. 8(5): 7216-7217, 2017.
McCarley R. Adenosine as a biological signal mediating sleepiness following prolonged wakefulness. Biol Sig Recept. 9(6):319-327, 2000.
Müller C, Schumacher B, Brattström A, et al. Interactions of valerian extracts and a fixed valerian–hop extract combination with adenosine receptors. Life Sci. 2002.
Liu Y, Zhao J, Guo W. Emotional roles of mono-aminergic neurotransmitters in major depressive disorder and anxiety disorders. Front Psychol. 9(2201), 2018.
Maurmann N, Reolon G, Rech S, et al. Valepotriate fraction of valeriana glechomifolia shows sedative and anxiolytic properties and impairs recognition but not aversive memory in mice. Evid Based Complement Altern Med. 2011.
Müller L, Salles L, Stein A, et al. Antidepressant-like effect of Valeriana glechomifolia Meyer (Valerianaceae) in mice. Prog Neuropsychopharmacol Biol Psychiatry. 36(1): 101-109, 2012.
Shi S, Shi J, Liu Y, et al. The anxiolytic effects of valtrate in rats involves changes of corticosterone levels. Evid Based Complement Altern Med. 2014.
Menard C, Pfau M, Hodes G, et al. Immune and neuroendocrine mechanisms of stress vulnerability and resilience. Neuropsychopharmacology. 42(1): 62-80, 2017.
Donath F, Quispe S, Diefenbach K, et al. Critical Evaluation of the Effect of Valerian Extract on Sleep Structure and Sleep Quality. Pharmacopsychiatry, 33(2): 47–53, 2000.
Chandra Shekhar H, Joshua L, Thomas JV. Standardized Extract of Valeriana officinalis Improves Overall Sleep Quality in Human Subjects with Sleep Complaints: A Randomized, Double-Blind, Placebo-Controlled, Clinical Study. Adv Ther. 2024 Jan;41(1):246-261.
Mills S en Bone K. Principles and Practice of Phytotherapy. Churchill Livingstone, twaalfde druk 2010.
Bent S, Padula A, Moore D, et al. Valerian for sleep: a systematic review and meta-analysis. Am J Med. 2006 Dec;119(12):1005-12.
Taibi DM, Vitiello MV, Barsness S, et al. A randomized clinical trial of valerian fails to improve self-reported, polysomnographic, and actigraphic sleep in older women with insomnia. Sleep Med. 2009 Mar;10(3):319-28.
Taibi DM, Landis CA, Petry H, et al. A systematic review of valerian as a sleep aid: safe but not effective. Sleep Med Rev. 2007 Jun;11(3):209-30.
Kelber O, Nieber K, Kraft K. Valerian: no evidence for clinically relevant interactions. Evid Based Complement Alternat Med. 2014;2014:879396.
Ahmadi M, Khalili H, Abbasian L, et al. Effect of Valerian in preventing neuropsychiatric adverse effects of efavirenz in HIV-positive patients: a pilot randomized, placebo-controlled clinical trial. Ann Pharmacother. 51(6): 457-464, 2017.
Farah G, Ferreira G, Danieletto-Zanna C, et al. Assessment of Valeriana officinalis l. (Valerian) for conscious sedation of patients during the extraction of impacted mandibular third molars: a randomized, split-mouth, double-blind, crossover study. J Oral Maxillofac Surg. 77(9), 2019.
Pinheiro M, Alcantara C, de Moraes M, et al. Valeriana officinalis L. for conscious sedation of patients submitted to impacted lower third molar surgery: a randomized, double-blind, placebo-controlled split-mouth study. J Pharm Bioallied Sci. 6(2): 109-114, 2014.
Behboodi Moghadam Z, Rezaei E, Shirood Gholami R, et al. The effect of Valerian root extract on the severity of pre menstrual syndrome symptoms. J Tradit Complement Med. 6(3): 309-315, 2016.
Roh D, Jung J, Yoon K, et al. Valerian extract alters functional brain connectivity: a randomized double-blind placebo-controlled trial. Phytother Res. 33(4): 939-948, 2019.
Shinjyo N, Waddell G, Green J. Valerian Root in Treating Sleep Problems and Associated Disorders-A Systematic Review and Meta-Analysis. J Evid Based Integr Med. 25, 2020.
Koetter U, Schrader E, Käufeler R, et al. A randomized, double blind, placebo-controlled, prospective clinical study to demonstrate clinical efficacy of a fixed valerian hops extract combination (Ze 91019) in patients suffering from non-organic sleep disorder. Phytother Res. 2007 Sep;21(9):847-51.
Gromball J, Beschorner F, Wantzen C, et al. Hyperactivity, concentration difficulties and impulsiveness improve during seven weeks' treatment with valerian root and lemon balm extracts in primary school children. Phytomedicine. 2014 Jul-Aug;21(8-9):1098-103.
Trompetter I, Krick B, Weiss G. Herbal triplet in treatment of nervous agitation in children. Wien Med Wochenschr 163:52–57, 2013.
Kennedy DO, Little W, Haskell CF, et al. Anxiolytic effects of a combination of Melissa officinalis and Valeriana officinalis during laboratory induced stress. Phytother Res. 2006 Feb;20(2):96-102.
Taavoni S, Nazem Ekbatani N, Haghani H. Valerian/lemon balm use for sleep disorders during menopause. Complement Ther Clin Pract. 2013 Nov;19(4):193-6.
Maroo N, Hazra A, Das T. Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial. Indian J Pharmacol. 45(1): 34-39, 2013.
Wähling C, Wegener T, Tschaikin M. Herbal triple combination: An effective alternative to benzodiazepines. Zeitschrift für Phytotherapie Vol. 30(2): 69-72, 2009.
Kelber O, Nieber K, Kraft K. Valerian: no evidence for clinically relevant interactions. Evid Based Complement Alternat Med. 2014;2014:879396.
